KANGAWA KENJI has a total of 22 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are PROLOR BIOTECH INC, ANERGIS SA and ALTAREX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Kangawa Kenji | 21 |
#2 | Hosoda Hiroshi | 20 |
#3 | Matsuo Hisayuki | 13 |
#4 | Kojima Masayasu | 13 |
#5 | Minamitake Yoshiharu | 12 |
#6 | Nojiri Takashi | 2 |
#7 | Okumura Meinoshin | 2 |
#8 | Hosada Hiroshi | 1 |
#9 | Furuya Mayumi | 1 |
#10 | Minamitake Yoshiharu; | 1 |
Publication | Filing date | Title |
---|---|---|
CA2523576A1 | Preventives or remedies for hepatopathy | |
US7385026B1 | Modified ghrelin polypeptides |